These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12684120)

  • 61. Bladder Neck Urothelial Carcinoma: A Urinary Bladder Subsite Carcinoma With Distinct Clinicopathology.
    Xiao GQ; Rashid H
    Int J Surg Pathol; 2015 Oct; 23(7):517-23. PubMed ID: 26092228
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cutaneous invasion from sarcomatoid urothelial carcinoma: clinical and dermatopathologic features.
    Bernardes Filho F; de Melo AS; Pires AR; Lupi O; das Neves DG; da Cruz MF; Kac BK
    An Bras Dermatol; 2016; 91(1):73-9. PubMed ID: 26982782
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
    Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K
    Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
    [TBL] [Abstract][Full Text] [Related]  

  • 64. H-RAS mutation is a key molecular feature of pediatric urothelial bladder cancer. A detailed report of three cases.
    Castillo-Martin M; Collazo Lorduy A; Gladoun N; Hyun G; Cordon-Cardo C
    J Pediatr Urol; 2016 Apr; 12(2):91.e1-7. PubMed ID: 26522772
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Behavior of urothelial carcinoma with respect to anatomical location.
    Catto JW; Yates DR; Rehman I; Azzouzi AR; Patterson J; Sibony M; Cussenot O; Hamdy FC
    J Urol; 2007 May; 177(5):1715-20. PubMed ID: 17437794
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Histopathological and immunohistochemical study of papillary urothelial neoplasms of low malignant potential and grade associated with extensive invasive low-grade urothelial carcinoma.
    Mai KT; Elmontaser G; Perkins DG; Yazdi HM; Stinson WA; Thijssen A
    BJU Int; 2004 Sep; 94(4):544-7. PubMed ID: 15329109
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A combination of p40, GATA-3 and uroplakin II shows utility in the diagnosis and prognosis of muscle-invasive urothelial carcinoma.
    Leivo MZ; Elson PJ; Tacha DE; Delahunt B; Hansel DE
    Pathology; 2016 Oct; 48(6):543-9. PubMed ID: 27594510
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Transient receptor potential vanilloid type 2 (TRPV2) expression in normal urothelium and in urothelial carcinoma of human bladder: correlation with the pathologic stage.
    Caprodossi S; Lucciarini R; Amantini C; Nabissi M; Canesin G; Ballarini P; Di Spilimbergo A; Cardarelli MA; Servi L; Mammana G; Santoni G
    Eur Urol; 2008 Sep; 54(3):612-20. PubMed ID: 17977643
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Nested variant urothelial carcinoma: diagnostic difficulties].
    Berthier A; Gobet F; Bugel H; Roquet L; Pfister C
    Prog Urol; 2005 Sep; 15(4):729-32. PubMed ID: 16459696
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Plasmacytoid urothelial carcinoma of the urinary bladder: a clinicopathologic study of 16 cases].
    Zhang W; Jiang YX; Liu Y; Yu WJ; Zhao H; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):433-7. PubMed ID: 24246859
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Histological variant as the significant predictor of survival in patients with lymph node positive urothelial carcinoma of the bladder.
    Kim HS; Moon KC; Jeong CW; Kwak C; Kim HH; Ku JH
    Sci Rep; 2015 May; 5():9626. PubMed ID: 25959144
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Primary clear-cell urothelial carcinoma of urinary bladder: a not-so-clear entity with review of literature.
    Kumar L; Narwal A; Kumar M; Kaushal S
    BMJ Case Rep; 2019 Oct; 12(10):. PubMed ID: 31645400
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [A diagnostic pitfall in the pathology of bladder tumors: the nested variant of urothelial carcinoma].
    Auriault ML; Comoz F; Bottet P; Bensadoun H
    Ann Pathol; 2000 Sep; 20(4):400-1. PubMed ID: 11015669
    [No Abstract]   [Full Text] [Related]  

  • 74. [Bladder tumors (transitional cell carcinoma)].
    Matsumoto K
    Gan No Rinsho; 1989 Jan; Spec No():430-41. PubMed ID: 2915492
    [No Abstract]   [Full Text] [Related]  

  • 75. E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup.
    Byrne RR; Shariat SF; Brown R; Kattan MW; Morton RA JR; Wheeler TM; Lerner SP
    J Urol; 2001 May; 165(5):1473-9. PubMed ID: 11342899
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Divergent differentiation in urothelial carcinoma and other bladder cancer subtypes with selected mimics.
    Shanks JH; Iczkowski KA
    Histopathology; 2009 Jun; 54(7):885-900. PubMed ID: 19178589
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Stage T1 bladder cancer: grade is the primary determinant for risk of muscle invasion.
    Kaubisch S; Lum BL; Reese J; Freiha F; Torti FM
    J Urol; 1991 Jul; 146(1):28-31. PubMed ID: 2056599
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Plasmacytoid variant of urothelial carcinoma: a report of a rare case.
    Demellawy DE; Ahmed AD; Bora B; Bonin M
    Pathol Res Pract; 2012 Sep; 208(9):561-4. PubMed ID: 22854197
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pseudocarcinomatous urothelial hyperplasia of the bladder: clinical findings and followup of 70 patients.
    Kryvenko ON; Epstein JI
    J Urol; 2013 Jun; 189(6):2083-6. PubMed ID: 23228381
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Skin metastasis of 'nested type' of urothelial carcinoma of the urinary bladder.
    Zwenzner EM; Kaatz M; Ziemer M
    J Cutan Pathol; 2006 Nov; 33(11):754-5. PubMed ID: 17083696
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.